Fresenius Medical Care (NYSE:FMS) Sees Strong Trading Volume – Should You Buy?

Shares of Fresenius Medical Care AG (NYSE:FMS) saw unusually-high trading volume on Wednesday . Approximately 740,733 shares traded hands during mid-day trading, an increase of 138% from the previous session’s volume of 310,951 shares.The stock last traded at $24.66 and had previously closed at $24.47.

Wall Street Analysts Forecast Growth

FMS has been the subject of several analyst reports. StockNews.com raised Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th. Truist Financial increased their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Finally, Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd.

Fresenius Medical Care Stock Down 1.4 %

The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The stock has a 50-day simple moving average of $23.82 and a 200-day simple moving average of $22.31. The firm has a market capitalization of $14.25 billion, a PE ratio of 20.07, a P/E/G ratio of 0.76 and a beta of 0.99.

Institutional Trading of Fresenius Medical Care

Large investors have recently bought and sold shares of the company. Smartleaf Asset Management LLC increased its position in Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock worth $28,000 after buying an additional 806 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Fresenius Medical Care in the third quarter worth $38,000. Russell Investments Group Ltd. boosted its holdings in shares of Fresenius Medical Care by 234.1% in the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company’s stock worth $71,000 after acquiring an additional 2,208 shares during the period. Jones Financial Companies Lllp boosted its holdings in shares of Fresenius Medical Care by 80.5% in the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company’s stock worth $102,000 after acquiring an additional 2,012 shares during the period. Finally, Venturi Wealth Management LLC boosted its holdings in shares of Fresenius Medical Care by 8.4% in the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company’s stock worth $129,000 after acquiring an additional 441 shares during the period. 8.37% of the stock is owned by hedge funds and other institutional investors.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.